Showing results (311-320 of 2,804) with videos related to
Sort By:
Pageof 281
Journal of Crohn'S & Colitis|November 26, 2013
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behaviorDiego Forni, Isabelle Cleynen, Marc Ferrante, et al.Journal of Crohn'S & Colitis|October 15, 2013
Comparing disease activity indices in ulcerative colitisA J Walsh, A Ghosh, A O Brain, et al.Journal of Crohn'S & Colitis|October 23, 2013
Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccineChang Kyun Lee, Hyun-Soo Kim, Byong Duk Ye, et al.Journal of Crohn'S & Colitis|September 27, 2013
Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective studyMei Lan Huang, Xi Tao Xu, Jun Shen, et al.Journal of Crohn'S & Colitis|May 25, 2012
A patient with ulcerative colitis and central serous chorioretinopathy--a therapeutic dilemmaBella Geyshis, Gabriel Katz, Shomron Ben-Horin, et al.Journal of Crohn'S & Colitis|June 8, 2012
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: effects of combined therapy with immunosuppressantsG Andrisani, D Frasca, M Romero, et al.Journal of Crohn'S & Colitis|September 22, 2018
Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel DiseaseKaren van Hoeve, Erwin Dreesen, Ilse Hoffman, et al.Journal of Crohn'S & Colitis|September 27, 2018
Anti-Tumour Necrosis Factor Therapy for Inflammatory Bowel Diseases Do Not Impact Serious Infections after ArthroplastyMartin H Gregory, Andrew McKinnon, Dustin Stwalley, et al.Journal of Crohn'S & Colitis|April 17, 2019
A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986-2015Sang Hyoung Park, Ye-Jee Kim, Kyoung Hoon Rhee, et al.Journal of Crohn'S & Colitis|April 17, 2019
Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort StudyClaire Liefferinckx, Bram Verstockt, Ann Gils, et al.Pageof 281